• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 18-22, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

 

April 18-22, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs4/20/11Washington, DCN/AArnim von Friedeburg (German Foods North America, LLC); Stephan Tromp (International Featured Standards)Food Safety Modernization Act
Meghan Scott, Acting Associate Commissioner for External Affairs4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research4/18/11-4/22/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/21/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Health Care Information and Management Systems SocietyMedical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/22/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from The Center for Medical Technology PolicyMedical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods4/21/11Silver Spring, MDDara Corrigan, Steven Solomon, Sharon Natanblut, Joseph Reardon, Peter Ashkenaz, John Verbeten, Roberta Wagner, Lawrence BachorikCourtney Brein, Tony Corbo, Sandra Eskin, Ami Gadhia, Dara Lieberman, Erik Olson, David Plunkett, Christopher Waldrop, Carol Tucker Foreman, Nancy Donley, Patricia Buck, Jean Halloran, Caroline Smith DeWaal, Sonia Roberts (Safe Food Coalition)Food Safety Legislation
Ralph Tyler, J.D., Chief Counsel4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/18/11-4/22/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/21/11Bethesda, MDDonna Mendrick, Timothy CoteFrancis Collins (National Institutes of Health); Donald Frail (Pfizer); Richard Gregg (Vitae Pharmaceuticals); Jerry Collins (National Cancer Institute)NIH-Industry Roundtable:  Exploring New Uses for Abandoned and Approved Therapeutics
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/22/11Bethesda, MDN/ASalvatore Sechi (National Institute of Diabetes and Digestive and Kidney Diseases); Simon Kasif (Boston University); Pierre DeMeyts (Novo-Nordisk); Ravi Lyengar (Mount Sinai School of Medicine)Drug Response- A Tool for Understanding the Systems Biology of Type 2 Diabetes